A recent report indicated that 7 out of the 63 women who were evaluated for for osteonecrosis of the jaw had been using only oral versions of bisphosphonates.(As opposed to the previously held theory that only those receiving IV bisphosphonates were at risk). Also, according to a Reuters report dated, 9-03-09, a trial in New York is the first of some 1,280 plantiff groups involving almost 900 cases over the U.S. claiming Fosamax caused ONJ. Osteoporosis is a bad condition. However, I think that it is important for persons who might just be receiving a recommendation from their MDs to start up with a bisphosphonate to understand both the risks and benefits. Some women are facing using the drugs for life.